Bronwen Bastone - 25 Jan 2023 Form 4 Insider Report for Enfusion, Inc. (ENFN)

Role
Chief People Officer
Signature
/s/ Matthew Campobasso, as Attorney-in-Fact
Issuer symbol
ENFN
Transactions as of
25 Jan 2023
Transactions value $
-$2,590
Form type
4
Filing time
27 Jan 2023, 18:23:19 UTC
Previous filing
09 Jan 2023
Next filing
27 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENFN Class A Common Stock Award $0 +638 +0.39% $0 163,639 25 Jan 2023 Direct F1
transaction ENFN Class A Common Stock Tax liability -$2,589 -218 -0.13% $11.88 163,421 25 Jan 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of fully vested shares issued under the Enfusion, Inc. 2021 Stock Option and Incentive Plan in connection with the previously disclosed pre-IPO termination of the Enfusion Ltd. LLC Change in Control Bonus Plan (the "Shares").
F2 Consists of shares withheld to satisfy tax withholding obligations resulting from delivery of the Shares to the reporting person.